Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients.
Ho TT, Perkins JB, Gonzalez R, Hicks JK, Martinez RA, Duranceau K, North B, Kim J, Teer JK, Yao J, Yoder SJ, Nishihori T, Bejanyan N, Pidala J, Elmariah H.
Ho TT, et al. Among authors: north b.
Pharmacogenomics. 2024 Jan;25(1):29-40. doi: 10.2217/pgs-2023-0204. Epub 2024 Jan 8.
Pharmacogenomics. 2024.
PMID: 38189154